ACR Convergence 2025 | Video: Rheuminations on Milestones & Ageism

Conditions

Subcategories:Axial Spondyloarthritis Clinical Criteria/Guidelines Gout and Crystalline Arthritis Myositis Osteoarthritis and Bone Disorders Other Rheumatic Conditions Pain Syndromes Pediatric Conditions Psoriatic Arthritis Rheumatoid Arthritis Sjögren’s Disease Soft Tissue Pain Systemic Lupus Erythematosus Systemic Sclerosis Vasculitis

Is an Onslaught of Pain on the Horizon?

Vanessa Caceres | February 12, 2011

Pain treatment varies based on race and gender, and many patients don’t receive optimal care

Family, Fatigue & Heart Health

Richard Sine | February 12, 2011

Researchers explore several factors in the health and well-being of patients with lupus

Chronotherapy with Glucorticoids in Rheumatoid Arthritis

Frank Buttgereit, MD | January 17, 2011

Time is of the essence in balancing risks and benefits

Phoning It In

Bruce N. Cronstein, MD | January 17, 2011

The missed message on methotrexate

A Review of Wegener’s Treatment Data

Vanessa Caceres | January 17, 2011

Clinical trials show changing role of existing treatment and introduction of newer medications

Treat JIA Without Slowing Growth

By Sue Pondrom | January 4, 2011

Etanercept does not impede normal height and weight development in these patients

Macrophage Activation Syndrome

Alexei A. Grom, MD | December 1, 2010

A review of diagnosis, treatment, and prognosis

Can Technology Help Solve Scleroderma Renal Crisis?

Murray Baron, MD | December 1, 2010

A case study in using the Internet to facilitate rare disease research

New GIOP Guidelines Available

From the College | December 1, 2010

The ACR published new recommendations for the management of glucocorticoid-induced osteoporosis (GIOP) in the November issue of Arthritis Care & Research. These guidelines have been endorsed by the American Society for Bone and Mineral Research. They apply to adult patients receiving oral glucocorticoid therapy.

Naturally Occurring Antibodies May Lead to New RA Therapies

From the College | December 1, 2010

A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body. These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.